scholarly journals Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications

Database ◽  
2015 ◽  
Vol 2015 (0) ◽  
pp. bav056-bav056 ◽  
Author(s):  
T. Heged s ◽  
P. M. Chaubey ◽  
G. Varady ◽  
E. Szabo ◽  
H. Saranko ◽  
...  
2008 ◽  
Vol 233 (12) ◽  
pp. 1510-1517 ◽  
Author(s):  
Swati S. Ghatpande ◽  
Pankaj K. Choudhary ◽  
Charles T. Quinn ◽  
Steven R. Goodman

2008 ◽  
Vol 4 ◽  
pp. T321-T321
Author(s):  
Joy G. Mohanty ◽  
Hemant D. Shukla ◽  
Satya Saxena ◽  
Jefferey D. Williamson ◽  
Lenore J. Launer ◽  
...  

2010 ◽  
Vol 73 (3) ◽  
pp. 619-626 ◽  
Author(s):  
Swati S. Ghatpande ◽  
Pankaj K. Choudhary ◽  
Charles T. Quinn ◽  
Steven R. Goodman

2010 ◽  
Vol 8 (1) ◽  
pp. 11 ◽  
Author(s):  
Joy G Mohanty ◽  
Hem D Shukla ◽  
Jefferey D Williamson ◽  
Lenore J Launer ◽  
Satya Saxena ◽  
...  

Pharmaceutics ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 99
Author(s):  
Xinyi Wu ◽  
Yichen Li ◽  
Faisal Raza ◽  
Xuerui Wang ◽  
Shulei Zhang ◽  
...  

Multiple drug resistance (MDR) in bacterial infections is developed with the abuse of antibiotics, posing a severe threat to global health. Tedizolid phosphate (TR-701) is an efficient prodrug of tedizolid (TR-700) against gram-positive bacteria, including methicillin-sensitive staphylococcus aureus (MSSA) and methicillin-resistant staphylococcus aureus (MRSA). Herein, a novel drug delivery system: Red blood cell membrane (RBCM) coated TR-701-loaded polylactic acid-glycolic acid copolymer (PLGA) nanoparticles (RBCM-PLGA-TR-701NPs, RPTR-701Ns) was proposed. The RPTR-701Ns possessed a double-layer core-shell structure with 192.50 ± 5.85 nm in size, an average encapsulation efficiency of 36.63% and a 48 h-sustained release in vitro. Superior bio-compatibility was confirmed with red blood cells (RBCs) and HEK 293 cells. Due to the RBCM coating, RPTR-701Ns on one hand significantly reduced phagocytosis by RAW 264.7 cells as compared to PTR-701Ns, showing an immune escape effect. On the other hand, RPTR-701Ns had an advanced exotoxins neutralization ability, which helped reduce the damage of MRSA exotoxins to RBCs by 17.13%. Furthermore, excellent in vivo bacteria elimination and promoted wound healing were observed of RPTR-701Ns with a MRSA-infected mice model without causing toxicity. In summary, the novel delivery system provides a synergistic antibacterial treatment of both sustained release and bacterial toxins absorption, facilitating the incorporation of TR-701 into modern nanotechnology.


2001 ◽  
Vol 81 (1) ◽  
pp. 43-56 ◽  
Author(s):  
Guillaume Lenormand ◽  
Sylvie Hénon ◽  
Alain Richert ◽  
Jacqueline Siméon ◽  
François Gallet

Sign in / Sign up

Export Citation Format

Share Document